Agios Pharmaceuticals Inc EV/EBIT
What is the EV/EBIT of Agios Pharmaceuticals Inc?
The EV/EBIT of Agios Pharmaceuticals Inc is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to Agios Pharmaceuticals Inc
What does Agios Pharmaceuticals Inc do?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Companies with ev/ebit similar to Agios Pharmaceuticals Inc
- Manugraph India has EV/EBIT of N/A
- Guild Esports Plc has EV/EBIT of N/A
- Clarity Gold has EV/EBIT of N/A
- Radha Madhav has EV/EBIT of N/A
- Acasti Pharma Inc has EV/EBIT of N/A
- Akers Biosciences Inc has EV/EBIT of N/A
- Agios Pharmaceuticals Inc has EV/EBIT of N/A
- Generation Bio Co has EV/EBIT of N/A
- Purple Biotech has EV/EBIT of N/A
- Panbela Therapeutics has EV/EBIT of N/A
- Continental Materials has EV/EBIT of N/A
- GlycoMimetics Inc has EV/EBIT of N/A
- Veritas Pharma has EV/EBIT of N/A